The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis

Gut

Volumn 60, Issue 12, 2011, Pages 1661-1670

  Sheng, Yong H ^a   Lourie, Rohan ^a   Lindén, Sara K ^b   Jeffery, Penny L ^a   Roche, Deborah ^a   Tran, Thu V ^a   Png, Chin W ^a   Waterhouse, Nigel ^a   Sutton, Philip ^c   Florin, Timothy H J ^a   McGuckin, Michael A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DEXTRAN SULFATE; INTERLEUKIN 1BETA; MESSENGER RNA; MUCIN; MUCIN 13; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIARRHEA; ENTERITIS; EPITHELIUM CELL; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MOUSE; MUC13; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECTUM HEMORRHAGE; WEIGHT REDUCTION;

ANIMALS; ANTIGENS, SURFACE; APOPTOSIS; CELL LINE; CELL PROLIFERATION; COLITIS; CYTOKINES; DEXTRAN SULFATE; EPIDERMAL GROWTH FACTOR; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; MUCINS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 80655124696     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2011.239194     Document Type: Article

References (39)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205. (Pubitemid 28307304)
2. Stappenbeck TS, Rioux JD, Mizoguchi A, et al. Crohn disease: a current perspective on genetics, autophagy and immunity. Autophagy 2010;7:1-19.
3. McGuckin MA, Eri R, Simms LA, et al. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 2009;15:100-13.
4. Johansson ME, Phillipson M, Petersson J, et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A 2008;105:15064-9.
5. Linden SK, Sutton P, Karlsson NG, et al. Mucins in the mucosal barrier to infection. Mucosal Immunol 2008;1:183-97. (Pubitemid 351541304)
6. Kufe DW. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 2009;9:874-85.
7. McGuckin MA, Linden SK, Sutton P, et al. Mucin dynamics and enteric pathogens. Nat Rev Microbiol 2011;9:265-78.
8. Meerzaman D, Shapiro PS, Kim KC. Involvement of the MAP kinase ERK2 in MUC1 mucin signaling. Am J Physiol Lung Cell Mol Physiol 2001;281:L86-91.
9. Singh PK, Hollingsworth MA. Cell surface-associated mucins in signal transduction. Trends Cell Biol 2006;16:467-76. (Pubitemid 44293402)
10. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 2004;4:45-60. (Pubitemid 38082153)
11. McAuley JL, Linden SK, Png CW, et al. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest 2007;117:2313-24. (Pubitemid 47219576)
12. McGuckin MA, Every AL, Skene CD, et al. Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. Gastroenterology 2007;133:1210-18. (Pubitemid 47494449)
13. Linden SK, Sheng YH, Every AL, et al. MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy. PLoS Pathog 2009;5:e1000617.
14. Heazlewood CK, Cook MC, Eri R, et al. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med 2008;5:e54.
15. Eri RD, Adams RJ, Tran TV, et al. An intestinal epithelial defect conferring ER stress results in inflammation involving both innate and adaptive immunity. Mucosal Immunol 2011;4:354-64.
16. Petersson J, Schreiber O, Hansson GC, et al. Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 2011;300:G327-33.
17. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010;42:1118-25.
18. Ho SB, Dvorak LA, Moor RE, et al. Cysteine-rich domains of muc3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing. Gastroenterology 2006;131:1501-17. (Pubitemid 44708946)
19. Luu Y, Junker W, Rachagani S, et al. Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis. Int J Biochem Cell Biol 2010;42:996-1006.
20. Williams SJ, Wreschner DH, Tran M, et al. Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J Biol Chem 2001;276:18327-36.
21. Walsh MD, Young JP, Leggett BA, et al. The MUC13 cell surface mucin is highly expressed by human colorectal carcinomas. Hum Pathol 2007;38:883-92. (Pubitemid 46735955)
22. Chauhan SC, Vannatta K, Ebeling MC, et al. Expression and functions of transmembrane mucin MUC13 in ovarian cancer. Cancer Res 2009;69:765-74.
23. Shimamura T, Ito H, Shibahara J, et al. Overexpression of MUC13 is associated with intestinal-type gastric cancer. Cancer Sci 2005;96:265-73. (Pubitemid 40895074)
24. Moehle C, Ackermann N, Langmann T, et al. Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease. J Mol Med 2006;84:1055-66.
25. Zhang B, Ren J, Yan X, et al. Investigation of the porcine MUC13 gene: isolation, expression, polymorphisms and strong association with susceptibility to enterotoxigenic Escherichia coli F4ab/ac. Anim Genet 2008;39:258-66.
26. Ren J, Tang H, Yan X, et al. A pig-human comparative RH map comprising 20 genes on pig chromosome 13q41 that harbours the ETEC F4ac receptor locus. J Anim Breed Genet 2009;126:30-6.
27. Jacobsen M, Kracht SS, Esteso G, et al. Refined candidate region specified by haplotype sharing for Escherichia coli F4ab/F4ac susceptibility alleles in pigs. Anim Genet 2010;41:21-5.
28. Linden SK, Florin TH, McGuckin MA. Mucin dynamics in intestinal bacterial infection. PLoS ONE 2008;3:e3952.
29. Johansson ME, Thomsson KA, Hansson GC. Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the muc2 mucin, is strongly bound to the Fcgbp protein. J Proteome Res 2009;8:3549-57.
30. Kitajima S, Takuma S, Morimoto M. Tissue distribution of dextran sulfate sodium (DSS) in the acute phase of murine DSS-induced colitis. J Vet Med Sci 1999;61:67-70. (Pubitemid 129581167)
31. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-41. (Pubitemid 38962578)
32. Johansson ME, Gustafsson JK, Sjoberg KE, et al. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One 2010;5:e12238.
33. Edelblum KL, Yan F, Yamaoka T, et al. Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflamm Bowel Dis 2006;12:413-24.
34. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009;361:2066-78.
35. Ren J, Agata N, Chen D, et al. Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents. Cancer Cell 2004;5:163-75. (Pubitemid 38283802)
36. Wei X, Xu H, Kufe D. Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene. Cancer Res 2007;67:1853-8. (Pubitemid 46383412)
37. Raina D, Kharbanda S, Kufe D. The MUC1 oncoprotein activates the anti-apoptotic phosphoinositide 3-kinase/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts. J Biol Chem 2004;279:20607-12. (Pubitemid 38656454)
38. Tait SW, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 2010;11:621-32.
39. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-33. (Pubitemid 37328672)